Details for New Drug Application (NDA): 020629

✉ Email this page to a colleague

NDA 020629 describes DENAVIR, which is a drug marketed by Mylan and is included in one NDA. It is available from one supplier. Additional details are available on the DENAVIR profile page.

The generic ingredient in DENAVIR is penciclovir. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the penciclovir profile page.

Summary for 020629

Tradename:	DENAVIR
Applicant:	Mylan
Ingredient:	penciclovir
Patents:	0

Pharmacology for NDA: 020629

Mechanism of Action	DNA Polymerase Inhibitors

Suppliers and Packaging for NDA: 020629

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DENAVIR	penciclovir	CREAM;TOPICAL	020629	NDA AUTHORIZED GENERIC	Mylan Pharmaceuticals Inc.	0378-0896	0378-0896-55	1 TUBE in 1 CARTON (0378-0896-55) / 5 g in 1 TUBE
DENAVIR	penciclovir	CREAM;TOPICAL	020629	NDA	Mylan Pharmaceuticals Inc.	0378-9720	0378-9720-55	1 TUBE in 1 CARTON (0378-9720-55) / 5 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CREAM;TOPICAL			Strength	1%
Approval Date:	Sep 24, 1996	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020629

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan	DENAVIR	penciclovir	CREAM;TOPICAL	020629-001	Sep 24, 1996	⤷ Subscribe	⤷ Subscribe
Mylan	DENAVIR	penciclovir	CREAM;TOPICAL	020629-001	Sep 24, 1996	⤷ Subscribe	⤷ Subscribe
Mylan	DENAVIR	penciclovir	CREAM;TOPICAL	020629-001	Sep 24, 1996	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.